Menu
My Activity Hub
Podcasts
Videos
Pricing
Feedback
Tutoring
Sign Up
Log In
My Activity Hub
Podcasts
Videos
How it works
Pricing
Tutoring
Sign Up
Log In
CME
HER2 Testing: The Evolving Role of Immunohistochemistry (IHC)
54 mins; April 14, 2025
Revolutionizing Diagnostic Precision: AI-Driven Approaches in Digital Pathology and HER2 Expression
26 mins; April 03, 2025
Establishing Best Practices for Collaborative Care for Patients with ASCVD Between Academic and Rural Providers
59 mins; April 02, 2025
A Scientific Look at FcRn Antagonists: Mechanisms of Action Explained
4 mins; April 01, 2025
Autoantibodies Explained: Anti-AChR, Anti-MuSK, and Their Diagnostic Role
4 mins; April 01, 2025
Diagnostic Advances in gMG: Effective Tools and Techniques
5 mins; April 01, 2025
Living with gMG: Navigating Personal, Professional, and Mental Health Challenges
4 mins; April 01, 2025
Managing Side Effects in FcRn Therapy: Best Practices for gMG
5 mins; April 01, 2025
New Frontiers in MG: How FcRn Antagonists Are Changing MG Therapy
4 mins; April 01, 2025
Ocular to Generalized MG: How and Why the Disease Evolves
5 mins; April 01, 2025
Precision Medicine for gMG: Tailoring Treatments Based on Patient Profiles
4 mins; April 01, 2025
Preventing Myasthenic Crisis: Early Signs and Critical Interventions
4 mins; April 01, 2025
Traditional MG Treatments: Balancing Benefits, Risks, and Side Effect Management
5 mins; April 01, 2025
Treatment Advances in Generalized Myasthenia Gravis: Clinical and Laboratory Criteria for Diagnosis and Optimal Treatment Selection
41 mins; April 01, 2025
Mode of Death in Patients With HFmrEF/HFpEF: The FINEARTS-HF Trial
4 mins; March 31, 2025
A Patient-Centered Approach to Diabetes Management
0 secs; March 31, 2025
Adherence To Insulin Therapies: Real-world Evidence
0 secs; March 31, 2025
Complications and Hospitalizations in Patients with T2D
0 secs; March 31, 2025
Defining Stable Glycemic Control
0 secs; March 31, 2025
How Do Once-weekly Basal Insulins Work?
0 secs; March 31, 2025
Insulin Therapy: Initiation, Titration and Monitoring
0 secs; March 31, 2025
Key Considerations of Once-weekly Basal Insulin in Clinical Practice
0 secs; March 31, 2025
Once-weekly Basal Insulins: Starting and Titrating
0 secs; March 31, 2025
Patient Experience - What It’s Like to Be Living with Daily Insulin Injections
0 secs; March 31, 2025
Redefining Convenience: Clinical Outcomes of Once-Weekly Basal Insulins
0 secs; March 31, 2025
Case Consult: Adverse Effect Monitoring, Management, and Mitigation During Targeted Therapy for BRAF-Mutant mCRC
0 secs; March 30, 2025
Defining the Standard of Care and Optimal Sequencing in BRAF-Mutant mCRC: Second Line and Beyond
5 mins; March 30, 2025
Mutational Testing in mCRC: Methods and Data Driving Treatment Selection
5 mins; March 30, 2025
Proactive Adverse Effect Management in mCRC: Improving Tolerability to Optimize Patient Outcomes
5 mins; March 30, 2025
Case Consult: Adverse Effect Monitoring, Management, and Mitigation During Targeted Therapy for BRAF-Mutant mCRC
5 mins; March 30, 2025
Distinguishing Between Anti-PD-1 Agents in ESCC Combination Therapies
5 mins; March 30, 2025
Effective Monitoring and Management of Adverse Effects in Metastatic ESCC
6 mins; March 30, 2025
From Guidelines to Practice: First-Line Treatment Choices in mCRC
5 mins; March 30, 2025
ICI Combination Regimens for First-Line Treatment of Metastatic ESCC
5 mins; March 30, 2025
Strategies for Navigating First-Line Treatment Selection in Metastatic ESCC
5 mins; March 30, 2025
Tailoring First-Line Regimens: Patient-Centric Selection in Metastatic ESCC
5 mins; March 30, 2025
The Impact of First-Line Treatment on Subsequent Treatment Options for Metastatic ESCC
5 mins; March 30, 2025
The Importance of PD-L1 Testing: Shaping the Future of Treatment in ESCC
6 mins; March 30, 2025
Antibody-Drug Conjugates in Bladder Cancer: Guideline Updates and Adverse Event Management
30 mins; March 25, 2025
Clinical Conundrums in ARIA: Communicating ARIA Risk with Patients Considering Anti-Aβ Therapy
6 mins; March 24, 2025
Clinical Conundrums in ARIA: Differential Diagnoses and Potential Pitfalls in ARIA Evaluation
6 mins; March 24, 2025
Clinical Conundrums in ARIA: Differentiating and Navigating ARIA vs Stroke When an Emergent MRI is Unavailable
7 mins; March 24, 2025
Clinical Conundrums in ARIA: Evolving Approaches to Mitigate ARIA Risk in Patients Prescribed Anti-Aβ mAbs
5 mins; March 24, 2025
Clinical Conundrums in ARIA: How to Interpret and Manage ARIA-H
6 mins; March 24, 2025
Clinical Conundrums in ARIA: How to Manage Asymptomatic ARIA
5 mins; March 24, 2025
Clinical Conundrums in ARIA: How to Manage Severe ARIA
5 mins; March 24, 2025
Clinical Conundrums in ARIA: Navigating the Baseline MRI for Anti-Aβ Monoclonal Antibodies
6 mins; March 24, 2025
Clinical Conundrums in ARIA: Nuances of Microhemorrhages when Evaluating an MRI for ARIA
6 mins; March 24, 2025
Clinical Conundrums in ARIA: Triage and Imaging in the Emergency Setting for Patients Prescribed Anti-Aβ mAbs
5 mins; March 24, 2025
Clinical Conundrums in ARIA: When is a Headache Concerning in Patients Prescribed Anti-Aβ mAbs?
5 mins; March 24, 2025
Second-Line Solutions in Metastatic TNBC: ADC Selection, Sequencing, and Safety
13 mins; March 24, 2025
Collaborative Insights to Solve the Puzzle of Bladder Cancer
60 hours 0 mins; March 13, 2025
Factoring Solutions to the Management of Stroke Care in the Settings of Secondary Prevention and AF
64 hours 0 mins; March 13, 2025
Personalizing Care Within the RCC Treatment Paradigm
58 mins; March 12, 2025
Accurate Diagnosis and Management of Hereditary Alpha Tryptasemia
8 mins; February 27, 2025
Advancing Multidisciplinary Care in TGCT: Integrating Systemic Therapies and Surgical Approaches
15 mins; February 27, 2025
Diagnosis and Treatment of Systemic Mastocytosis With an Associated Hematologic Neoplasm
8 mins; February 27, 2025
Differential Diagnosis of Indolent Systemic Mastocytosis
6 mins; February 27, 2025
Is it Nonresponsive/Progressive ISM?
7 mins; February 27, 2025
Consequences of COVID-19: Addressing Infection-Associated Chronic Conditions
2 mins; February 23, 2025
Exploring New and Emerging Treatments in Muscle Invasive Bladder Cancer
6 mins; February 20, 2025
Patient Perspectives on Bladder Cancer
9 mins; February 20, 2025
Reviewing the Latest Bladder Cancer Practice Guidelines
6 mins; February 20, 2025
Patient Case Study: Cancer-Associated Thrombosis
5 mins; February 13, 2025
Don't Miss It! Rapid & Accurate AAV Diagnosis
5 mins; February 13, 2025
Elevating Care for Patients With Severe Renal Disease in AAV
5 mins; February 13, 2025
How Do We Translate Real-World AF Data Into Everyday Clinical Practice?
4 mins; February 13, 2025
How Do We Translate Real-World VTE Data Into Everyday Clinical Practice for Ongoing Anticoagulation?
5 mins; February 13, 2025
Implementing the SOC Induction Therapies in AAV
5 mins; February 13, 2025
Implications Associated With Integrating Both Real-World Data and Clinical Trial Data Into Clinical Practice: AF Considerations
6 mins; February 13, 2025
Implications Associated With Integrating Both Real-World Data and Clinical Trial Data Into Clinical Practice: VTE Considerations
5 mins; February 13, 2025
Managing Patients With AAV in the Rheumatology Clinic
6 mins; February 13, 2025
Optimizing AAV Outcomes: Maintenance Therapies
5 mins; February 13, 2025
Patient Case Study: Elderly
6 mins; February 13, 2025
Patient Case Study: Obesity and VTE
6 mins; February 13, 2025
Patient Case Study: Obesity
5 mins; February 13, 2025
Setting the Stage of Real-World Data vs RCT
5 mins; February 13, 2025
Tailoring Treatment for Optimal Outcomes in Patients With AAV
5 mins; February 13, 2025
Trade off: Ischemic/Thrombotic vs Bleeding
5 mins; February 13, 2025
Differentiating Agents in the Expanding HER2-Targeted Arsenal for Metastatic Breast Cancer
10 mins; February 05, 2025
HER2-Targeted TKI Combinations in Second-Line and Beyond MBC
4 mins; February 05, 2025
Leveraging Clinical Data: HER2-Targeted ADCs in Second-Line and Beyond MBC
5 mins; February 05, 2025
Optimizing Treatment Selection for HER2+ Breast Cancer Patients with Brain Metastases
7 mins; February 05, 2025
Sequencing Strategies for Second-Line and Beyond Treatment of HER2+ MBC
7 mins; February 05, 2025
Systemic Management of Brain Metastases in HER2+ BC: Emerging Strategies and Treatment Approaches
7 mins; February 05, 2025
Understanding CNS Lesions in HER2+ Metastatic Breast Cancer
6 mins; February 05, 2025
Virtual Tumor Board: Maximizing the Potential of Immuno-Oncology in Early TNBC Through Personalized Care
16 mins; February 04, 2025
Beyond the Broadcast: Expert Insights on SGLT2 Inhibitors in Cardiometabolic Care
13 mins; February 03, 2025
Classification/Suspecting a Diagnosis of FNAIT/NAIT
4 mins; January 30, 2025
Current Diagnostic Signs, Symptoms, and Lab Tests for FNAIT
4 mins; January 30, 2025
Current Management Strategies for FNAIT
5 mins; January 30, 2025
Fetal/Neonatal Alloimmune Thrombocytopenia (FNAIT): The Platelet Equivalent of Rh Disease
5 mins; January 30, 2025
Key Patient Counseling Issues Surrounding FNAIT and Its Risk in Subsequent Pregnancies
5 mins; January 30, 2025
Managing the “Next Pregnancy” in Patients With an FNAIT-Affected First Child
5 mins; January 30, 2025
Neonatal FcRn Inhibition: A New Pathway for Addressing the Alloimmune Disorders of Pregnancy
3 mins; January 30, 2025
Nipocalimab: An FcRn Inhibitor and Its Role in Treating HDFN
4 mins; January 30, 2025
No Patient Left Behind! Advancing CKD-Associated Pruritus Care
13 mins; January 30, 2025
Screening for FNAIT: Anticipating HPA-1a Incompatibility
4 mins; January 30, 2025
The Alloimmune Disorders of Pregnancy
3 mins; January 30, 2025
The Safety of Sodium Oxybate in Treating Narcolepsy
31 mins; January 30, 2025
Click here to see more
‹ Prev
1
2
3
4
5
6
7
8
Next ›
